afzelii-IgG antibodies in AE, GBS, and IBD patients; 13–22 % of all tested sera were anti-Campylobacter IgA and IgG antibody and anti-Borrelia IgG antibody double positive (Table 3). Here, CD79A is linked to inflammatory bowel disease.